VeriSIM Life Secures $15 Million Series A Funding
VeriSIM Life (VeriSIM) www.verisimlife.com , the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced it has closed its oversubscribed $15 million Series A round.
- VeriSIM Life (VeriSIM) www.verisimlife.com , the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced it has closed its oversubscribed $15 million Series A round.
- With its first-in-class platform, VeriSIM is transforming the way pharmaceutical and biotech companies address the most challenging diseases impacting humankind.
- This new funding will allow us to accelerate our growth and bring the future of more efficient, cost-effective clinical trials to life.
- For more information about VeriSIM Life follow them on Twitter at @VeriSIMlife and visit: www.verisimlife.com or email [email protected] .